Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Saroglitazar vs Pioglitazone in NAFLD
NCT02265276Phase 3Unknown
- Sponsor
- Command Hospital
- Start
- Oct 2014
- Primary completion
- Sep 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of saroglitazar in non-alcoholic fatty liver disease (NAFLD), sponsored by Command Hospital. Status: unknown.
02
Drugs
saroglitazar
03
Conditions
non-alcoholic fatty liver disease (NAFLD)
Beyond the preview
Go deeper on NCT02265276.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02265276.